Skip to content

4Accepted Oct 8, 9:50 PM ET

TRex Bio: director Carol Giltner Gallagher received 17,500 shares

TRXBTRex Bio, Inc.

Accepted (ET)

9:50 PM

Oct 8, 2026

Filed

Oct 8, 2026

Documents

1

Size

5.3 KB

Summary

TRex Bio: director Carol Giltner Gallagher received 17,500 shares

Updated

What happened Carol Giltner Gallagher, director, received 17,500 derivative shares as a grant (transaction code A) on Oct 8, 2026, at $0.00 per share, total value $0.00, as reported on the Form 4 filed Oct 8, 2026.

Key details

  • Transaction date and price: Oct 8, 2026; 17,500 shares; $0.00 per share; code A (award/grant); derivative security.
  • Shares owned after the transaction: not specified in the filing.
  • Footnote F1: the option vests in full on Oct 8, 2027, subject to the reporting person's continued service through such date.
  • Filing information: period of report Oct 8, 2026; Form 4 filed Oct 8, 2026.

Why it may matter

  • The filing reports a derivative award that vests in full on Oct 8, 2027, subject to continued service.
  • This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing